BioSpace News Archive

Drug Development

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome

January 14, 2014
·
5 min read
Drug Development

Nektar Therapeutics (CA) Release: Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis For BEACON Pivotal Phase 3 Clinical Study In Patients With Metastatic Breast Cancer

January 14, 2014
·
10 min read
Policy

Smithers Pira Lansing Laboratory Achieves Key Accreditation For Medical Device And Pharmaceutical Product Testing

January 14, 2014
·
1 min read
ProSensa Holding N.V. To Provide Corporate Update To Key Stakeholders

January 14, 2014
·
1 min read
Pharm Country

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Study For Second Opioid Abuse Deterrent Product

January 14, 2014
·
1 min read
Symphogen A/S Presents Corporate Progress And Outlook At JP Morgan’s 32nd Annual Healthcare Conference In San Francisco, CA

January 14, 2014
·
1 min read
Business

Osiris Therapeutics, Inc. Board Confirms Lode Debrabandere, PhD, MBA, As President And Chief Executive Officer

January 14, 2014
·
5 min read
Immunocore Limited To Present At 32nd Annual JP Morgan Healthcare Conference And To Provide An Update On Lead Program For Melanoma

January 14, 2014
·
3 min read
Drug Development

Tekmira Pharmaceuticals Corporation Doses First Subject In Human Clinical Trial Of TKM-Ebola

January 14, 2014
·
1 min read
Biotech Bay

Symphogen A/S Presents Corporate Progress And Outlook At JP Morgan’s 32nd Annual Healthcare Conference In San Francisco, CA

January 14, 2014
·
2 min read